- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03342222
The Safety and Effectiveness of PEEK Interference Screws in Anterior Cruciate Ligament Reconstruction
Multi-center, Randomized, Open, Parallel, Noninferiority Clinical Trial to Evaluate the Safety and Effectiveness of PEEK Interference Screws in Anterior Cruciate Ligament Reconstruction
Anterior cruciate ligament (ACL) rupture is one of the most common injuries in sports medicine. ACL reconstructions are usually performed to restore the stability of knee joint and prevent the secondary meniscal and chondral lesions.
120 Subjects with ACL injury were randomly assigned to two groups for ACL reconstruction.Group one: tibial fixation with PEEK Interference Screws (Rejoin Hangzhou Martins Medical Equipment Co., Ltd.);Group two: tibial fixation with Biosure PK interference screw (Smith & Nephew plc). The subjects will be followed by 12 months after surgery for evaluations.Outcome measures included Lysholm score,IKDC, ADT,Lachman.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
Hunan
-
Changsha, Hunan, China, 410008
- Recruiting
- Xiangya Hospital, Central South University
-
Contact:
- Lu Hongbin, M.D. & Ph.D.
- Phone Number: 86-0731-84327174
- Email: hongbinlu@hotmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Voluntarily sign the informed consent form; Between the ages of 18 and 75; Positive ADT and positive Lachman test. Unilateral anterior cruciate ligament is confirmed by MRI (without posterior cruciate ligament injury or reconstruction); Tolerated for anterior cruciate ligament reconstruction surgery; Normal contralateral knee
Exclusion Criteria:
- Do not meet the diagnostic criteria of anterior cruciate ligament injury;
- With posterior cruciate ligament fracture at the same time;
- X-ray showed a significant degeneration of the knee (more than four degrees of cartilage injury);
- Knee flexion less than 90 degree;
- Abnormal body anatomy;
- Pregnant, breast-feeding or subjects who plan to become pregnant;
- Serious osteoporosis, malignant tumors;
- Allergic to implant materials;
- Patients with severe malnutrition who can not tolerate surgery;
- Severe coagulopathy, such as hemophilia;
- Immunodeficiency diseases, including those requiring long-term use of immunosuppressive agents;
- The injured knee has a wide range of skin diseases;
- Serious obese patients (BMI> 35);
- Patients with severe mental illness can not cooperate with postoperative rehabilitation and patients with severe cardiopulmonary disease can not tolerate surgery;
- Ipsilateral lower extremity received surgery within the past year;
- Has participated in any other clinical trial in the past three months;
- Can not comply with the requirements of the study;
- Those who the investigator thinks they are inappropriate.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: PEEK Interference Screws
PEEK Interference Screws provided by Ruijin Hangzhou Martins Medical Equipment Co., Ltd.
|
tibial fixation for ACL reconstruction
|
|
Active Comparator: Biosure PK interference screw
Biosure PK interference screw from Smith & Nephew plc.
|
tibial fixation for ACL reconstruction
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
percentage of patients with Lysholm score more than 70 score
Time Frame: 12 month
|
12 month
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Lysholm score
Time Frame: 1month; 3month; 6 month; 12 month
|
1month; 3month; 6 month; 12 month
|
|
IKDC
Time Frame: 1month; 3month; 6 month; 12 month
|
1month; 3month; 6 month; 12 month
|
|
Anterior drawer test
Time Frame: 1month; 3month; 6 month; 12 month
|
1month; 3month; 6 month; 12 month
|
|
Lachman test
Time Frame: 1month; 3month; 6 month; 12 month
|
1month; 3month; 6 month; 12 month
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- JMST-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.